Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharmaceutical symbols : SNY save search
FDA Greenlights New Antibiotic for SAB, Pneumonia
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -1.81%
PRGO | News | $30.8 2.87% -1.14% 1.2M
|
Health Technology
|
| O: -0.22%
H: 0.8%
C: 0.06%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.37%
H: 1.42%
C: 1.37%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
fda for
FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published: 2024-04-03 (Crawled : 13:30) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M
|
Health Technology
|
| O: -0.29%
H: 1.34%
C: -0.64%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.11%
H: 0.37%
C: -0.77%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
fda drug schizophrenia
AstraZeneca Kicks Off April With New PNH Approval
Published: 2024-04-02 (Crawled : 13:30) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M
|
Health Technology
|
| O: -1.09%
H: 0.13%
C: -1.39%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.77%
H: 0.8%
C: 0.74%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.18%
H: 0.47%
C: 0.12%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.14%
H: 0.02%
C: -1.06%
approval astrazeneca
XORTX Announces New Clinical Advisory Board Member - March 27, 2024
Published: 2024-03-27 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
XRTX | $3.5 -3.05% -3.14% 12K
|
Mining, Quarrying, and Oil and ...
|
| O: 0.0%
H: 0.0%
C: -5.79%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nods for DMD, Hypertension
Published: 2024-03-22 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
PRGO | News | $30.8 2.87% -1.14% 1.2M
|
Health Technology
|
| O: 0.35%
H: 0.99%
C: -1.17%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.43%
H: 0.41%
C: -0.85%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.47%
H: 0.23%
C: -0.19%
fda hypertension
Innate Pharma Reports Full Year 2023 Financial Results and Business Update
Published: 2024-03-21 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -4.51%
H: 4.25%
C: 0.96%
pharma business year update financial results
Incyte Gets Phase II Win, Targets Blockbuster Dupixent in Skin Disease
Published: 2024-03-11 (Crawled : 16:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
disease dupixent skin
FDA Rejects Viatris, Mapi’s Long-Acting Multiple Sclerosis Injection
Published: 2024-03-11 (Crawled : 14:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
fda sclerosis injection
FDA Decisions: Multiple Issues Cited in Rejection of Minerva’s Schizophrenia Hopeful
Published: 2024-02-29 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.6%
H: 0.0%
C: 0.0%
PRGO | News | $30.8 2.87% -1.14% 1.2M
|
Health Technology
|
| O: 0.11%
H: 0.98%
C: -0.68%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.56%
H: 0.12%
C: -0.38%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.22%
H: 0.1%
C: -1.4%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: 0.0%
fda schizophrenia
GSK, Sanofi Exit Nigerian Market Amid Lingering Foreign Exchange Crisis
Published: 2024-02-28 (Crawled : 06:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
sanofi market
Denali Secures $500M in Financing, Focuses on Large Molecule Biotherapeutics
Published: 2024-02-27 (Crawled : 17:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
FDA Decisions: Allecra Succeeds Where Competitors Failed; Another Humira Copycat
Published: 2024-02-27 (Crawled : 15:00) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M
|
Health Technology
|
| O: -10.69%
H: 0.0%
C: -4.98%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.07%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.44%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
fda humira
TL1A Inhibitors Could Usher in New Era for IBD Treatment
Published: 2024-02-26 (Crawled : 05:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.82%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
treatment
Innate Pharma Announces Its Participation to Upcoming March 2024 Investor Conference
Published: 2024-02-21 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.57%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -2.32%
H: 0.0%
C: 0.0%
pharma conference
Sanofi, Denali ALS Candidate Flops in Mid-Stage Trial
Published: 2024-02-19 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
candidate als trial
FDA Decisions: Sanofi/Regeneron's Dupixent Racks Up Another Pediatric Indication
Published: 2024-02-02 (Crawled : 15:00) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M
|
Health Technology
|
| O: -0.53%
H: 1.28%
C: 0.53%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.57%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
fda dupixent
J&J, Merck CEOs Agree to Testify Before Senate Panel and Dodge Subpoena
Published: 2024-01-29 (Crawled : 15:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
merck
Sanders Confident of Senate Panel’s Support for Subpoenaing J&J, Merck CEOs
Published: 2024-01-26 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.8%
H: 0.0%
C: -1.82%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
merck
Senator Sanders Warns J&J, Merck CEOs Could Be Subpoenaed on Drug Pricing
Published: 2024-01-19 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: -0.83%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.23%
H: 0.0%
C: 0.0%
drug merck
Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024
Published: 2024-01-12 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.0%
H: 0.36%
C: 0.36%
pharma
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.